Printer Friendly

Browse Dapagliflozin topic

Articles

1-167 out of 167 article(s)
Title Author Type Date Words
Safety of the new anti-diabetic medications. Jul 3, 2021 518
DARE-19 Trial Finds Dapagliflozin Well Tolerated in Hospitalized COVID-19 Patients. Jun 28, 2021 531
American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. Jun 28, 2021 254
American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. Jun 28, 2021 253
AstraZeneca's Farxiga gets US approval in chronic kidney disease. May 5, 2021 211
AstraZeneca's Farxiga gets US approval in chronic kidney disease. May 5, 2021 212
AstraZeneca's Farxiga gets US approval in chronic kidney disease. May 5, 2021 213
AstraZeneca hails progress on chronic kidney disease with US approval. May 3, 2021 218
TOP NEWS SUMMARY: Eurozone manufacturing growth "stellar" in April. May 3, 2021 1567
Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression with and without Type 2 Diabetes. May 3, 2021 232
SGLT2 inhibitors: A revolution in therapeutics of a Major Non-Communicable Disease. Khan, Muhammad Sami Apr 30, 2021 676
Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. Apr 12, 2021 256
Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. Apr 12, 2021 255
Medicines to help asthma and migraines among drugs given green light for use in Scotland; Four new medicines to help severe asthma, migraines, heart failure and bone marrow cancer have been approved for use by NHS Scotland. Gary Flockhart Apr 12, 2021 422
Heart Failure Is a Treatable Condition, Not a Death Sentence: Manage heart failure with medication, a low-sodium diet, and other lifestyle choices to enjoy a full, active life. Mar 31, 2021 1047
SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute(MIDEM). Erum Sohail, Tasnim Ahsan, Saima Ghaus and Wasfa Aijaz Feb 24, 2021 3564
New drug for heart failure gets FDA approval. Feb 18, 2021 774
FDA approves AstraZeneca's Dapagliflozin to treat heart failure. Feb 1, 2021 592
AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease. Jan 6, 2021 303
AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease. Jan 6, 2021 299
AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease. Jan 6, 2021 304
Overcoming Therapeutic Inertia: Practical Approaches. Brunton, Stephen A.; Miller, Eden M. Report Dec 1, 2020 6031
Type 2 Diabetes 2021-Beyond Glucose. Brunton, Stephen A. Dec 1, 2020 1735
AstraZeneca's Forxiga Approved For Use In Japan On Robust Test Results. Nov 30, 2020 220
TOP NEWS: AstraZeneca Maintains Annual Guidance As Profit Doubles. Nov 5, 2020 608
Philippine FDA approves new indication for diabetes drug. Oct 28, 2020 634
Diabetics at higher risk of dying from COVID-19. Oct 27, 2020 744
AstraZeneca announces positive results for Farxiga DAPA-CKD Phase III trial in patients with chronic kidney disease. Oct 26, 2020 268
AstraZeneca announces positive results for Farxiga DAPA-CKD Phase III trial in patients with chronic kidney disease. Oct 26, 2020 264
GLOBAL TOP NEWS SUMMARY: China GDP Growth "Envy Of Many Economies". Oct 19, 2020 1356
AstraZeneca's Forxiga And Trixeo Aerosphere Get Positive EU Opinions. Oct 19, 2020 351
Repurposing trials for COVID-19, cerebral palsy underway. Submitted by Barbara Goodman Sep 30, 2020 833
Euglycemic Ketoacidosis in a Patient with Metastatic Non-Small-Cell Lung Adenocarcinoma and Concomitant Pulmonary Embolism. O'Neill, Robert Sean; Tyack, Lauren; Freeman, Mary; Hussein, Hussein Soudy Aug 31, 2020 1927
AstraZeneca's Farxiga Gets Positive Results For Chronic Kidney Disease. Aug 31, 2020 243
GLOBAL TOP NEWS SUMMARY: Nestle Set To Buy US's Aimmune Therapeutics. Aug 31, 2020 1803
SGLT2 inhibitors show clinically meaningful effects in patients without diabetes. Zoler, Mitchel L. Aug 1, 2020 1944
TOP NEWS: AstraZeneca Kidney Disease Drug Farxiga Successful In Trial. Jul 28, 2020 180
GLOBAL TOP NEWS SUMMARY: Stocks Mixed Ahead Of US Fed Two-Day Meeting. Jul 28, 2020 1643
UK TOP NEWS SUMMARY: Reckitt Gets Virus Boost For Cleaning Products. Jul 28, 2020 1677
ERTUGLIFLOZIN FOR T2D: Cardiovascular death benefit lacking. Zoler, Mitchel L. Drug overview Jul 1, 2020 1310
Cardiovascular death benefit lacking with ertugliflozin. Zoler, Mitchel L. Jul 1, 2020 1297
Evelo Biosciences advances EDP1815 to Phase 2/3 TACTIC-E COVID-19 Trial. Jun 22, 2020 421
New Generics Get Approval From FDA. May 18, 2020 327
AI VIVO Seeks Collaboration Partners to Progress Top-ranked COVID-19 Therapeutic Candidates. May 7, 2020 480
The FDA authorises the new Farxiga oral treatment for heart failure patients with reduced ejection fraction. Drug overview May 6, 2020 237
The FDA authorises the new Farxiga oral treatment for heart failure patients with reduced ejection fraction. Drug overview May 6, 2020 241
TOP NEWS: AstraZeneca's Farxiga Wins US Approval In Heart Failure. May 6, 2020 197
LONDON MARKET OPEN: Tepid Start After German Factory Orders Plummet. May 6, 2020 1035
GLOBAL TOP NEWS SUMMARY: European PMIs At Historic Lows As Virus Bites. May 6, 2020 1777
UK TOP NEWS SUMMARY: UK Construction Activity Sinks To Record Low. May 6, 2020 1094
George Clinical collaborates with Saint Luke's Mid America Heart Institute. May 1, 2020 161
George Clinical collaborates with Saint Luke's Mid America Heart Institute. May 1, 2020 165
FARXIGA Phase III DAPA-CKD Trial Will Be Stopped Early After Overwhelming Efficacy in Patients with Chronic Kidney Disease. Apr 2, 2020 358
AstraZeneca's Farxiga Trial Ends Early Due To "Overwhelming Efficacy". Mar 30, 2020 402
Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. Gurkan, Eren Mar 1, 2020 2882
Diabetes Drugs Lower Heart Failure Risk: A new study shows that SGLT2s can help people without diabetes too. Russell, Stuart Feb 1, 2020 583
Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction. Jan 6, 2020 1143
Dapagliflozin equally effective for those with and without diabetes. Zoler, Mitchel L. Dec 1, 2019 959
A dapagliflozin labeling change comes next. O'Connor, Christopher M. Dec 1, 2019 384
How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area. Canivell, Silvia; Mata-Cases, Manel; Vlacho, Bogdan; Gratacos, Monica; Real, Jordi; Mauricio, Didac; Nov 30, 2019 6844
European Commission grants approval to AstraZeneca's diabetes drug Qtrilmet. Nov 19, 2019 191
European Commission grants approval to AstraZeneca's diabetes drug Qtrilmet. Nov 19, 2019 187
Consistent Effects of Farxiga in Heart Failure Patients with Reduced Ejection Fraction Shown in New Analyses from Landmark Phase III DAPA-HF Trial. Nov 19, 2019 921
AstraZeneca reports approval of Qtrilmet by EU for the treatment of type-2 diabetes. Nov 18, 2019 310
AstraZeneca reports approval of Qtrilmet by EU for the treatment of type-2 diabetes. Nov 18, 2019 311
European Commission Gives Approval To AstraZeneca Diabetes Drug. Nov 15, 2019 102
LONDON BRIEFING: Amerisur, Eddie Stobart And Carpetright Accept Offers. Nov 15, 2019 1642
Qtrilmet approved in the EU for the treatment of type-2 diabetes. Nov 15, 2019 623
Groundbreaking diabetes drug trial aims to revolutionise future treatment in Scotland. Nov 14, 2019 366
World Diabetes Day sees launch of landmark drug trial which could revolutionise future treatment for type 1 diabetes. Nov 14, 2019 779
BMI influences SGLT2-inhibitor effects in type 1 diabetes. Freeman, Sara Nov 1, 2019 1977
An Efficient and Practical Method for the Synthesis of Saxagliptin Intermediate 2-(3-Hydroxy-1-adamantane)-2-oxoacetic Acid and Its Optimization. Liao, Qi; Jiang, Lan; Li, Cong; Shen, Yaling; Wang, Min; Cao, Chengkun; Hu, Xiangnan Oct 31, 2019 4056
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes. Oct 22, 2019 1066
AstraZeneca (NYSE: AZN) - Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes -- 21/10/2019. Oct 22, 2019 391
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes. Oct 21, 2019 1066
TOP NEWS: AstraZeneca's Farxiga Granted US Heart Failure Risk Approval. Oct 21, 2019 238
SGLT2 Inhibitors Protect Against Kidney Disease in T2DM; Reduction seen for risk of dialysis, transplantation, or death due to kidney disease. Oct 10, 2019 237
Drug shows potential in reducing heart failure deaths. Oct 10, 2019 806
How to prioritize CV risk reduction in type 2 diabetes. Oct 5, 2019 1162
Dapagliflozin transforms from antidiabetic to heart failure drug. Zoler, Mitchel L. Oct 1, 2019 624
AstraZeneca's Qtrilmet recommended for approval in EU by CHMP for type 2 diabetes. Sep 24, 2019 243
AstraZeneca's Qtrilmet recommended for approval in EU by CHMP for type 2 diabetes. Sep 24, 2019 247
AstraZeneca (NYSE: AZN) - Qtrilmet recommended for approval in EU by CHMP for the treatment of type-2 diabetes -- 23/9/2019. Sep 24, 2019 249
Qtrilmet recommended for approval in EU by CHMP for the treatment of type-2 diabetes. Sep 23, 2019 633
AstraZeneca says Qtrilmet recommended for approval in EU by CHMP. Sep 23, 2019 138
Dapagliflozin Lowers Risk for Worsening Heart Failure; Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes. Sep 23, 2019 302
AstraZeneca (NYSE: AZN) - FDA grants Fast Track designation for Farxiga in heart failure -- 16/9/2019. Sep 18, 2019 251
Biotech Stock On The Radar: vTv Therapeutics's Diabetes Pipeline. Sep 17, 2019 1319
Biotech Stock On The Radar: vTv Therapeutics' Diabetes Pipeline. Sep 17, 2019 1319
FDA grants Fast Track designation for Farxiga in heart failure. Sep 16, 2019 1238
Three to four hundred thousand people annually lose feet and legs in Pakistan due to diabetic foot ulcers-Prof. Abdul Basit. Sep 11, 2019 3257
AstraZeneca reports on detailed results of phase III DAPA HF trial. Sep 3, 2019 166
AstraZeneca reports on detailed results of phase III DAPA HF trial. Sep 3, 2019 162
Detailed Results from Phase III DAPA-HF Trial Showed Farxiga Significantly Reduced Both the Incidence of Cardiovascular Death and the Worsening of Heart Failure. Sep 3, 2019 165
AstraZeneca (NYSE: AZN) - Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure -- 1/9/2019. Sep 3, 2019 482
Drug hope for heart failure patients. Sep 2, 2019 169
Diabetes drug's new role. Sep 2, 2019 168
Diabetes drug cuts heart risks. Sep 2, 2019 116
Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure. Sep 2, 2019 215
Common diabetes drug 'proves effective against heart failure' RESEARCH. Sep 2, 2019 257
TOP NEWS: Astra Reports Positive Study Results For Brilinta, Farxiga. Sep 2, 2019 254
WINNERS & LOSERS SUMMARY: Astra Higher On Positive Heart Trial Results. Sep 2, 2019 1081
TOP NEWS SUMMARY: Pound Slides As UK PM Johnson Threatens De-Selection. Sep 2, 2019 1555
LONDON MARKET MIDDAY: FTSE 100 Index Outperforms As Sterling Suffers. Sep 2, 2019 940
AstraZeneca to present data at ESC Congress 2019 that potentially redefine the treatment of heart failure. Aug 29, 2019 1267
FDA grants Fast Track designation for Farxiga in chronic kidney disease. Aug 27, 2019 1190
AstraZeneca reports positive results for Farxiga from phase III DAPA-HF trial. Aug 21, 2019 323
AstraZeneca reports positive results for Farxiga from phase III DAPA-HF trial. Aug 21, 2019 319
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure. Aug 20, 2019 1512
AstraZeneca (NYSE: AZN) - Forxiga label updated in the EU in type-2 diabetes -- 5/8/2019. Aug 6, 2019 242
AstraZeneca reports approval in EU for Forxiga label update in type-2 diabetes. Aug 5, 2019 265
Forxiga label updated in the EU in type-2 diabetes. Aug 5, 2019 825
AstraZeneca reports approval in EU for Forxiga label update in type-2 diabetes. Aug 5, 2019 261
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes. Jul 16, 2019 252
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes. Jul 16, 2019 248
AstraZeneca - Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data -- 1/7/2019. Jul 4, 2019 204
AstraZeneca reports recommendation of EU CHMP for Forxiga's marketing authorisation to include DECLARE-TIMI 58 CV outcomes data. Jul 2, 2019 331
AstraZeneca reports recommendation of EU CHMP for Forxiga's marketing authorisation to include DECLARE-TIMI 58 CV outcomes data. Jul 2, 2019 327
Iran Unveils 7 New Knowledge-Based Products. Jun 19, 2019 467
Iran Unveils 9 New Home-Made Hi-Tech Drugs. Jun 18, 2019 405
Farxiga Study Showed Reduced Progression of Kidney Disease or Renal Death in Patients with Type 2 Diabetes. Jun 11, 2019 136
Iran Boasts 3.3% Rise in Medicine Production. Jun 6, 2019 518
ADA Issues Updated Care Recommendations. Jun 3, 2019 597
Dapagliflozin's cardiac benefits bloom in T2D and prior MI. Jancin, Bruce Jun 1, 2019 958
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF. Jancin, Bruce Jun 1, 2019 404
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy. Papadokostaki, Eleni; Liberopoulos, Evangelos May 31, 2019 3214
HMC issues advisory on medications during Ramadan. May 20, 2019 1226
Simultaneous Estimation of Saxagliptin and Dapagliflozin in Human Plasma by Validated High Performance Liquid Chromatography - Ultraviolet Method/Saksagliptin ve Dapagliflozin Tarafindan Dogrulanmis Yuksek Performansli Sivi Kromatografi - Ultraviyole Yontemi Insan Plazma Es Zamanli Tahmin. Donepudi, Sharmila; Achanta, Suneetha Report May 17, 2019 4686
Iran Industrializes Home-Made Drug to Treat Liver Cancer. May 12, 2019 390
AstraZeneca - Qternmet XR approved in the US for the treatment of type-2 diabetes -- 3/5/2019. May 7, 2019 164
US Food and Drug Administration approves Qternmet XR. May 7, 2019 174
US Food and Drug Administration approves Qternmet XR. May 7, 2019 170
Iran Unveils 4 New Drugs for Treating Cancer, Diabetes. May 7, 2019 551
Iran Vows to Indigenize Sanctioned Medicine. May 7, 2019 661
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 155
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 153
AstraZeneca's Qternmet XR approved by US FDA for type-2 diabetes. May 6, 2019 151
Iran Develops Know-How for Production of 4 Vital Cancer, Diabetes Drugs. May 6, 2019 427
Dapagliflozin beneficial in type 2 diabetes with prior Ml. Jancin, Bruce May 1, 2019 1063
Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population-The Pakistan perspective. Report Apr 30, 2019 6076
Correlation of Serum 1,5-AG with Uric Acid in Type 2 Diabetes Mellitus with Different Renal Functions. Zhang, Kai; Xue, Bizhen; Yuan, Yuexing; Wang, Yao Mar 31, 2019 5415
Diabetes Is a Major Risk Factor for Heart Disease: Lifestyle modifications can help protect your heart health. Mar 30, 2019 767
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 353
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 354
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. Mar 28, 2019 349
European Commission approves AstraZeneca's Forxiga. Mar 27, 2019 214
European Commission approves AstraZeneca's Forxiga. Mar 27, 2019 210
ADA updates 2019 diabetes Standards of Care, adds recommendation on Vascepa. Mar 27, 2019 289
AstraZeneca's Forxiga approved in Europe for type-1 diabetes. Mar 26, 2019 382
AstraZeneca's Forxiga approved in Europe for type-1 diabetes. Mar 26, 2019 383
First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of Farxiga in Type 2 Diabetes. Mar 20, 2019 648
US FDA expands approval of AstraZeneca's Farxiga and Xigduo XR. Mar 1, 2019 256
US FDA expands approval of AstraZeneca's Farxiga and Xigduo XR. Mar 1, 2019 252
SGLT2 INHIBITORS: Benefits in heart failure. Jancin, Bruce Mar 1, 2019 928
Managing glycaemic variability: Clinical approach. Report Feb 28, 2019 1657
SGLT2 inhibitors may increase the risk of serious adverse events. Drug overview Feb 28, 2019 692
US FDA Approves Expanded Farxiga and Xigduo XR Labels for Use in Patients with Type 2 Diabetes and Moderate Renal Impairment. Feb 28, 2019 214
AstraZeneca announces FDA approval for expanded FARXIGA, XIGDUO XR labels. Feb 27, 2019 233
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Lucero, Pablo; Chapela, Sebastian Jan 1, 2018 4500
Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy. Cho, Eun Hyung; Park, Se-Jun; Han, Seongwook; Song, Ji Hun; Lee, Kihwang; Chung, Yoo-Ri Jan 1, 2018 4574
Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience. Scorsone, Alessandro; Saura, Gabriella; Fleres, Mattia; Spano, Lucia; Aiello, Vito; Brancato, Davide Jan 1, 2018 3403
Quality of Methodological Reporting of Randomized Clinical Trials of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors. Alfahmi, Hadeel; Aldawood, Lina; Baz, Bayan; Elrggal, Mahmoud; Alsharif, Hadeel Yahya; Alkahtani, Sa Apr 1, 2017 2298
In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets. de Meira, Rafaela Zielinski Cavalheiro; Maciel, Aline Biggi; Murakami, Fabio Seigi; de Oliveira, Pau Report Jan 1, 2017 3539
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic [ApoE.sup.-/-] Mice. Leng, Weiling; Ouyang, Xinshou; Lei, Xiaotian; Wu, Mingxia; Chen, Liu; Wu, Qinan; Deng, Wuquan; Lian Report Jan 1, 2017 6375
Nice recommends new drug for some with type 2 diabetes. Brief article Jul 1, 2013 283
FDA rejects novel antidiabetes Drug, citing bladder and breast cancer risks. Tucker, Miriam E. Feb 1, 2012 1012
Bristol-Myers Squibb and AstraZeneca announce receipt of complete response letter from FDA for Dapagliflozin. Jan 20, 2012 196

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |